Guardant Health director exercises 154 RSUs

Guardant Health, Inc. director Steve E. Krognes reported a routine equity compensation event involving 154 shares.

Rhea-AI Filing Summary

Guardant Health, Inc. director Steve E. Krognes reported a routine equity compensation event involving 154 shares. He exercised restricted stock units into 154 shares of Common Stock, classified as a derivative exercise rather than an open-market purchase or sale. Following this transaction, he holds 19,516 shares of Common Stock directly and 155 Restricted Stock Units.

The RSUs come from an award granted on August 9, 2022 that vested 25% of the shares on June 30, 2023, with the remaining 75% vesting in substantially equal monthly installments over three years. No shares were sold, gifted, or withheld for taxes in this filing.

Insider Trade Summary

154 shares exercised/converted

Exercise 2 txns

Insider Krognes Steve E.

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	154	$0.00	$0.00
Exercise	Common Stock	154	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 155 contracts (Direct); Common Stock — 19,516 shares (Direct)

Footnotes (2)

1. F1. This represents a restricted stock unit award granted on August 9, 2022 that vested 25% of the shares subject to such award on June 30, 2023. The remaining 75% of the shares subject to such award vests in substantially equal installments each month during the three-year period thereafter.
2. F2. Not applicable for Restricted Stock Units.

Key Figures

RSUs exercised: 154 shares Common Stock after transaction: 19,516 shares RSUs remaining: 155 units +3 more

6 metrics

RSUs exercised 154 shares Restricted Stock Units converted to Common Stock

Common Stock after transaction 19,516 shares Direct holdings of Steve E. Krognes following exercise

RSUs remaining 155 units Restricted Stock Units position after reported transactions

Exercise price per RSU $0.00 per share Reported transaction price for RSU conversion

RSU grant date August 9, 2022 Original award date for the reported RSUs

Initial vesting tranche 25% of award Vested on June 30, 2023 per footnote

Key Terms

Restricted Stock Units, derivative exercise/conversion, substantially equal installments

3 terms

Restricted Stock Units financial

"This represents a restricted stock unit award granted on August 9, 2022 that vested 25% of the shares"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

derivative exercise/conversion financial

"transaction_action: derivative exercise/conversion for 154.0000 Restricted Stock Units"

substantially equal installments financial

"The remaining 75% of the shares subject to such award vests in substantially equal installments"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Guardant Health (GH) disclose for Steve E. Krognes?

Guardant Health disclosed that director Steve E. Krognes exercised restricted stock units into 154 Common Stock shares. This was recorded as a derivative exercise, not an open-market trade, and forms part of his ongoing equity compensation rather than a discretionary stock purchase or sale.

Did Steve E. Krognes buy or sell Guardant Health (GH) shares on the market?

No open-market transaction occurred. The Form 4 shows a derivative exercise of 154 restricted stock units into Common Stock, with no reported sales, gifts, or tax-withholding dispositions. The activity reflects scheduled equity vesting rather than a market-driven buy or sell decision.

How many Guardant Health (GH) shares does Steve E. Krognes hold after this Form 4?

After the reported transactions, Steve E. Krognes holds 19,516 shares of Guardant Health Common Stock directly, plus 155 Restricted Stock Units. These figures combine his existing equity position with the newly settled 154-share RSU vesting disclosed in this filing.

What are the terms of Steve E. Krognes’s Guardant Health RSU grant?

The RSU award was granted on August 9, 2022, vesting 25% of the shares on June 30, 2023. The remaining 75% vests in substantially equal monthly installments over three years, creating a steady schedule of share delivery tied to continued service.

Does this Guardant Health (GH) Form 4 indicate a tax-withholding or restructuring event?

No. The transaction summary shows zero shares for tax withholding, gifts, or restructuring-related entries. Only a 154-share derivative exercise of restricted stock units and the corresponding RSU position update are reported for Steve E. Krognes in this Form 4.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/01/2026 - 05:30 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Krognes Steve E.

(Last) (First) (Middle)

3100 HANOVER STREET

(Street)

PALO ALTO CALIFORNIA 94304

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Guardant Health, Inc. [ GH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/31/2026		M		154	A	$0	19,516	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0	05/31/2026		M			154	(1)	(2)	Common Stock	154	$0	155	D

Explanation of Responses:

1. This represents a restricted stock unit award granted on August 9, 2022 that vested 25% of the shares subject to such award on June 30, 2023. The remaining 75% of the shares subject to such award vests in substantially equal installments each month during the three-year period thereafter.

2. Not applicable for Restricted Stock Units.

Remarks:

	/s/ John Saia, as attorney-in-fact for Steve Krognes	06/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)